| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

* Centro de Química-Física Molecular, Instituto Superior Técnico, P-1049-001 Lisbon, Portugal;
Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, P-1749-016 Lisbon, Portugal
Correspondence: Address reprint requests to Ana Coutinho, Fax: 351-21-8464455; E-mail: pcacoutinho{at}mail.ist.utl.pt.
Nystatin interaction with liposomes mimicking fungal and mammalian membranes (ergosterol- and cholesterol-containing 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) large unilamellar vesicles, respectively) was studied by fluorescence spectroscopy. The activity of this antibiotic was also measured using a pyranine fluorescence detected K+/H+ exchange assay. Nystatin mean fluorescence lifetime varied with the antibiotic concentration and ergosterol content (030 mol%) of the lipid vesicles. It sharply increased from 5 to 37 ns upon reaching 100 molecules per liposome, reporting nystatin oligomerization in the membrane. Concomitantly, spectral alterations typical of excitonic coupling were detected and there was a pronounced increase in the initial rate of pore formation by nystatin. These findings suggest that nystatin exerts its antibiotic activity via a two-stage mechanism: at low antibiotic concentrations, surface-adsorbed monomeric antibiotic molecules perturb the lipid packing, changing the permeability properties of the ergosterol-rich liposomes. Upon reaching a critical threshold, nystatin mode of action switches to the classical model of transmembrane aqueous channel formation. In the presence of cholesterol-containing POPC liposomes, neither nystatin spectroscopic properties, nor the kinetics of K+ efflux varied with the antibiotic concentration suggesting that in this case the first stage of antibiotic mode of action always prevails or the assemblies formed by nystatin and cholesterol are very loose.
This article has been cited by other articles:
![]() |
A. Livraghi, M. Mall, A. M. Paradiso, R. C. Boucher, and C. M. P. Ribeiro Modelling Dysregulated Na+ Absorption in Airway Epithelial Cells with Mucosal Nystatin Treatment Am. J. Respir. Cell Mol. Biol., April 1, 2008; 38(4): 423 - 434. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Wilson-Ashworth, Q. Bahm, J. Erickson, A. Shinkle, M. P. Vu, D. Woodbury, and J. D. Bell Differential Detection of Phospholipid Fluidity, Order, and Spacing by Fluorescence Spectroscopy of Bis-pyrene, Prodan, Nystatin, and Merocyanine 540 Biophys. J., December 1, 2006; 91(11): 4091 - 4101. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Helrich, J. A. Schmucker, and D. J. Woodbury Evidence that Nystatin Channels Form at the Boundaries, Not the Interiors of Lipid Domains Biophys. J., August 1, 2006; 91(3): 1116 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Silva, A. Coutinho, A. Fedorov, and M. Prieto Competitive Binding of Cholesterol and Ergosterol to the Polyene Antibiotic Nystatin. A Fluorescence Study Biophys. J., May 15, 2006; 90(10): 3625 - 3631. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |